Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 28,400

Document Document Title
WO/2012/035303A2
The present invention relates to a novel process for synthesis of ramelteon, and key intermediates for the synthesis of ramelteon.  
WO/2012/035855A1
The present invention addresses the problem of providing a collagen production promoter, a hyaluronic acid production promoter and a wrinkle ameliorating agent which contain dehydrocostuslactone.  
WO/2012/035171A2
A compound of formula (I), wherein A is S, O or a double bond, and L is a substituted thiazolyl, phenyl or pyridyl. The compound is useful for the treatment of inflammation and cancer.  
WO/2012/034472A1
Cyano benzenedicarboxamide compounds of formula (I), preparing methods and as agricultural insecticides uses thereof. The compounds have broad-spectrum insecticidal activities.  
WO/2012/035303A8
The present invention relates to a novel process for synthesis of ramelteon, and key intermediates for the synthesis of ramelteon.  
WO/2012/035171A3
A compound of formula (I), wherein A is S, O or a double bond, and L is a substituted thiazolyl, phenyl or pyridyl. The compound is useful for the treatment of inflammation and cancer.  
WO/2012/035303A3
The present invention relates to a novel process for synthesis of ramelteon, and key intermediates for the synthesis of ramelteon.  
WO/2012/032389A2
The present invention relates to fosamprenavir calcium (la) substantially free of isomer impurity, (3R) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]- 1-benzyl-2-(phosphonooxy)propyl carbamate (lb), and its ...  
WO/2012/033631A2
Embodiments of the invention relate to compounds and methods for controlling algal growth, for example, in bodies of water or surfaces exposed to algae. Provided are compounds having algicidal activities and methods of use of these compo...  
WO/2012/032534A2
The present invention relates to Furanose derivatives and their applications in synthesis of statins.  
WO/2012/032534A3
The present invention relates to compounds of formula XXII and their synthesis from furanose derivatives as shown hereunder. Compounds of formula XXII are of use in the synthesis of statins.  
WO/2012/032389A3
The present invention relates to fosamprenavir calcium (la) substantially free of isomer impurity, (3R) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]- 1-benzyl-2-(phosphonooxy)propyl carbamate (lb), and its ...  
WO/2012/033631A3
Embodiments of the invention relate to compounds and methods for controlling algal growth, for example, in bodies of water or surfaces exposed to algae. Provided are compounds having algicidal activities and methods of use of these compo...  
WO/2012/032545A1
The invention relates to process for the preparation of benzofuran derivative and intermediates thereof. More particularly, it relates to processes for the preparation of dronedarone or pharmaceutically acceptable acid addition salts the...  
WO/2012/033019A1
Provided are: a novel acrylic ester derivative which can serve as a constituent unit in a high-molecular compound that is to be incorporated into a photoresist composition; a high-molecular compound obtained by polymerizing a raw materia...  
WO/2012/029672A1
The present invention relates to amine derivatives each represented by chemical formula (I) (wherein Ar represents a phenyl group or the like; R1 represents a hydrogen atom or the like; R2 represents a C1-6 alkylcarbonyl group or the lik...  
WO/2012/029942A1
Provided is a compound represented by formula (1) or a pharmacologically acceptable salt thereof. (In the formula, A represents a C6-10 arylene group or the like; R1a, R1b and R1c each independently represents a hydrogen atom, a halogen ...  
WO/2012/029758A1
The purpose of the present invention is to provide a photosensitive resin composition having high photosensitivity, excellent transparency in a cured film, and wide developing tolerance, and to provide a method for forming a cured film u...  
WO/2012/030619A1
Continuous flow systems and methods produce succinic anhydride by a double carbonylation of ethylene oxide with carbon monoxide and at least one catalyst. In some embodiments, the double carbonylation occurs using a single catalyst. In o...  
WO/2012/031298A3
Disclosed are compounds of formulae (I), (II), and (II)I: and pharmaceutically acceptable salts thereof, wherein the variables, R, R1, R2, R3, R101, L, D, Q, Y, X, and Z are defined herein. These compounds are useful for treating Gram-ne...  
WO/2012/031298A2
Disclosed are compounds of formulae (I), (II), and (II)I: and pharmaceutically acceptable salts thereof, wherein the variables, R, R1, R2, R3, R101, L, D, Q, Y, X, and Z are defined herein. These compounds are useful for treating Gram-ne...  
WO/2012/029071A3
The water tolerant heterogeneous acid catalyst (ICaT-2) has been disclosed herein. The catalyst of the invention comprises of rare earth metals in the form of trifluromethansulphonate anchored with hexagonal organic-inorganic functionali...  
WO/2012/029949A1
In the disclosed novel technique for producing, by hydrogenation of furans, tetrahydrofuran derivatives, which are hydrogenated products produced by hydrogenation of the starting materials furfural or furfuryl alcohol. The method of prod...  
WO/2012/025701A1
Compounds selected from the following group and their salts are inhibitors of HDAC activity, useful in the treatment of, inter alia, cell proliferative disease and inflammation: Cyclopentyl 1 -[({5-[(1E)-3-(hydroxyamino)-3-oxoprop-1-en-1...  
WO/2012/024818A1
Naphtho[2,3-b]furan-4,9-diones and naphtho[2,3-b]thiophene-4,9-diones, the preparation methods and uses thereof are disclosed. The pharmaceutical compositions comprising such compounds for the treatment of various indications including p...  
WO/2012/026886A1
The invention includes a compound represented by the following structural formula: wherein R is described herein. The compounds of the invention are useful in staining embryonic stem cells.  
WO/2012/024353A1
The present invention concerns the synthesis of 5-methyl-2-furoic acid, including ester, amide, and thioester derivatives of such from 5-(chloromethyl)-2-furaldehyde (CMF). The molecules so prepared are useful as intermediates for pharma...  
WO/2012/022467A3
The present invention relates to novel benzoquinone derivatives. The compounds are efficient as modulators of mitochondrial function and as such are useful for the treatment of pathological conditions where mitochondrial function is impa...  
WO/2012/023584A1
Provided are a composition derived from ascorbic acid, a method for preparing the composition, and a cosmetic material having the composition mixed therein. The composition derived from ascorbic acid comprises a reaction product obtained...  
WO/2012/021981A1
The present invention describes phytochemicals present in maple syrup and maple tree extracts by butanol, ethyl acetate and methanol. Novel compounds are isolated from maple syrups, including one compound Quebecol generated in the maple ...  
WO/2012/024276A1
Ethoxylated fatty acid mono-ester(s) of sorbitan with a fatty acid chain length from 8 to 14 and an overall degree of ethoxylation from 7 to 16 are new (though related to the polysorbates). These compounds are useful as adjuvants in agro...  
WO/2012/019428A8
Benzohydrol derivatives of formula (I), a preparation method, pharmaceutical compositions and pharmaceutical use thereof are disclosed in the invention. The derivatives can be used as rennin inhibitors to prepare the drugs for the treatm...  
WO/2012/019428A1
Benzohydrol derivatives of formula (I), a preparation method, pharmaceutical compositions and pharmaceutical use thereof are disclosed in the invention. The derivatives can be used as rennin inhibitors to prepare the drugs for the treatm...  
WO/2012/017166A2
or an addition salt thereof with pharmaceutically acceptable acids, for use thereof in a method for treatment of a pathological condition linked to an excessive effect of TNF-alpha and for use thereof in a method for treatment of the hum...  
WO/2012/017052A1
Process for the synthesis of 2,5-furandicarboxylic acid through the oxidation of -hydroxymethylfurfural in a flow of oxygenor a compound containing oxygen, catalysed by a supported catalyst containing a metal of the platinum group, carri...  
WO/2012/017166A3
or an addition salt thereof with pharmaceutically acceptable acids, for use thereof in a method for treatment of a pathological condition linked to an excessive effect of TNF-alpha and for use thereof in a method for treatment of the hum...  
WO/2012/015265A1
Provided are novel organic electroluminescent compounds and an organic electroluminescent device using the same. Because the organic electroluminescent device using the organic electroluminescent compound as a hole transport material or ...  
WO/2012/014818A1
Disclosed are the following ether compound, and the use of the same. In formula (1), n represents 0 or 1, m represents an integer of 0-2, Y represents -O-, -S-, -C (=O) -O- and -O- C (=O) -, X1 and X2 represent a hydrogen atom or a fluor...  
WO/2012/014181A1
The invention relates to compounds of formula (I) for use in the prevention and/or treatment of viral infections: Wherein X, Y, Z, T, R1a and R1b are as defined in claim 1.  
WO/2012/015616A1
Methods for the production of dehydrated sugars and derivatives of dehydrated sugars using microwave (MW) irradiation and methods of purifying the same are described. The dehydrated sugars derivatives include 5-hydroxymethyl-2-furfural (...  
WO/2012/013016A1
The invention relates to the field of medicine. Curcumalactone derivatives with antitumor activity and the process for their preparation are disclosed. The said curcumalactone derivatives and their oxidized derivatives have a spironolact...  
WO/2012/014779A1
Disclosed is an organic electroluminescent element having the following attributes in high degree: high luminous efficiency, durability, low drive voltage, and inhibition of decreased luminous efficiency after high-temperature storage. A...  
WO/2012/010174A1
The present invention is concerned with a process in connection with the purification of a pharmaceutically acceptable salt of escitalopram or citalopram.  
WO/2012/012278A2
Disclosed are compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically related to GPR35, and/or GPR35-hERG signaling complex. For example, disclosed are compounds for preventing and/or treat...  
WO/2012/012278A3
Disclosed are compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically related to GPR35, and/or GPR35-hERG signaling complex. For example, disclosed are compounds for preventing and/or treat...  
WO/2012/010802A1
The invention relates to a process for preparing benzofuran derivatives of general formula I, in which R represents a nitro or ester-COOR' group, where R' represents an alkyl group, R1 represents hydrogen or an alkyl group and R2 represe...  
WO/2012/010555A1
The present invention discloses novel compounds useful for the inhibition of IL-6/STAT signaling and/or PI3K/ NF-ĸΒ signaling in the treatment of associated diseases or conditions, e.g. cancer. A pharmaceutical composition comprising s...  
WO/2012/010788A1
The invention relates to a process for preparing 5-aminobenzoylbenzofuran derivatives of formula (I), in which R1 represents hydrogen or an alkyl group and R2 represents hydrogen, an alkyl, alkoxy or dialkylaminoalkoxy group, by reductio...  
WO/2012/011128A1
A process for preparing the prostaglandin derivatives is provided, wherein the benzoyl and p-nitrobenzoyl groups are used as the hydroxyl protective groups. A pharmaceutical composition comprising the prostaglandin derivatives is also pr...  
WO/2012/011125A1
The present invention relates to compounds that have the ability to modulate the activity of GPR40 and are therefore useful in the treatment of GPR40 related disorders. In addition the invention relates to the compounds, methods for thei...  

Matches 701 - 750 out of 28,400